Skip to main content
Erschienen in: Journal of Neurology 8/2015

01.08.2015 | Original Communication

Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014

verfasst von: Akihiko Ueda, Mitsuharu Ueda, Akihito Nagatoshi, Teruyuki Hirano, Takaaki Ito, Nobutaka Arai, Eiichiro Uyama, Kota Mori, Masaaki Nakamura, Satoru Shinriki, Katsuyoshi Ikeda, Yukio Ando

Erschienen in: Journal of Neurology | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

This study elucidates the genotypic and phenotypic spectrum and histopathological findings related to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in Japan. For this single-center retrospective observational study, we enrolled 215 patients who were clinically suspected of having CADASIL and were examined at Kumamoto University from 1997 to 2014, and we diagnosed CADASIL in 70 patients. We found 19 different NOTCH3 mutations in the patients, with the NOTCH3 Arg133Cys mutation being found most frequently. We also found the Arg75Pro mutation, a cysteine-sparing NOTCH3 mutation. CADASIL patients with this Arg75Pro mutation were frequently found throughout Japan, and fewer patients with the Arg75Pro mutation showed MRI hyperintensity in the anterior temporal pole compared with patients with other NOTCH3 mutations. Significantly more CADASIL patients with the NOTCH3 Arg133Cys mutation had hyperintensity in the external capsule compared with CADASIL patients with the other mutations not including the NOTCH3 Arg75Pro mutation. We also showed postmortem pathological findings of the first Japanese CADASIL case with the NOTCH3 Arg133Cys mutation, and histopathological findings of fresh frozen skin biopsy specimens of CADASIL patients. In conclusions, the spectrum of NOTCH3 mutations in Japanese CADASIL patients may be partially explained by founder effects. Genotype–phenotype correlations may exist in CADASIL, which should be considered so as to make an accurate diagnosis of CADASIL in each population. Fresh frozen skin biopsy specimens may aid detection of Notch3 deposits on vascular walls for an improved diagnosis of CADASIL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Joutel A, Corpechot C, Ducros A et al (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710CrossRefPubMed Joutel A, Corpechot C, Ducros A et al (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710CrossRefPubMed
3.
Zurück zum Zitat Joutel A, Andreux F, Gaulis S et al (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105:597–605PubMedCentralCrossRefPubMed Joutel A, Andreux F, Gaulis S et al (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105:597–605PubMedCentralCrossRefPubMed
4.
5.
Zurück zum Zitat Pescini F, Nannucci S, Bertaccini B et al (2012) The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke 43:2871–2876CrossRefPubMed Pescini F, Nannucci S, Bertaccini B et al (2012) The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke 43:2871–2876CrossRefPubMed
6.
Zurück zum Zitat Opherk C, Peters N, Herzog J et al (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 127:2533–2539CrossRefPubMed Opherk C, Peters N, Herzog J et al (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 127:2533–2539CrossRefPubMed
7.
Zurück zum Zitat Kim YE, Yoon CW, Seo SW et al (2014) Spectrum of NOTCH3 mutations in Korean patients with clinically suspicious cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurobiol Aging 35:726.e1–726.e6CrossRef Kim YE, Yoon CW, Seo SW et al (2014) Spectrum of NOTCH3 mutations in Korean patients with clinically suspicious cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurobiol Aging 35:726.e1–726.e6CrossRef
8.
Zurück zum Zitat Lee YC, Liu CS, Chang MH et al (2009) Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol 256:249–255CrossRefPubMed Lee YC, Liu CS, Chang MH et al (2009) Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese. J Neurol 256:249–255CrossRefPubMed
9.
Zurück zum Zitat Uyama E, Tokunaga M, Suenaga A et al (2000) Arg133Cys mutation of Notch3 in two unrelated Japanese families with CADASIL. Intern Med 39:732–737CrossRefPubMed Uyama E, Tokunaga M, Suenaga A et al (2000) Arg133Cys mutation of Notch3 in two unrelated Japanese families with CADASIL. Intern Med 39:732–737CrossRefPubMed
10.
Zurück zum Zitat Uchino M, Hirano T, Uyama E et al (2002) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and CADASIL-like disorders in Japan. Ann N Y Acad Sci 977:273–278CrossRefPubMed Uchino M, Hirano T, Uyama E et al (2002) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and CADASIL-like disorders in Japan. Ann N Y Acad Sci 977:273–278CrossRefPubMed
11.
Zurück zum Zitat Abe K, Murakami T, Matsubara E et al (2002) Clinical Features of CADASIL. Ann N Y Acad Sci 977:266–272CrossRefPubMed Abe K, Murakami T, Matsubara E et al (2002) Clinical Features of CADASIL. Ann N Y Acad Sci 977:266–272CrossRefPubMed
12.
Zurück zum Zitat Ishida C, Sakajiri K, Yoshita M et al (2006) CADASIL with a novel mutation in exon 7 of NOTCH3 (C388Y). Intern Med 45:981–985CrossRefPubMed Ishida C, Sakajiri K, Yoshita M et al (2006) CADASIL with a novel mutation in exon 7 of NOTCH3 (C388Y). Intern Med 45:981–985CrossRefPubMed
13.
Zurück zum Zitat Mizuno T, Muranishi M, Torugun T et al (2008) Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue. Intern Med 47:2067–2072CrossRefPubMed Mizuno T, Muranishi M, Torugun T et al (2008) Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue. Intern Med 47:2067–2072CrossRefPubMed
14.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808CrossRef Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808CrossRef
15.
Zurück zum Zitat Pantoni L, Pescini F, Nannucci S et al (2010) Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology 74:57–63CrossRefPubMed Pantoni L, Pescini F, Nannucci S et al (2010) Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients. Neurology 74:57–63CrossRefPubMed
16.
Zurück zum Zitat Fazekas F, Chawluk JB, Alavi A et al (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Neuroradiol 8:421–426 Fazekas F, Chawluk JB, Alavi A et al (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Neuroradiol 8:421–426
17.
Zurück zum Zitat Scheltens P, Barkhof F, Valk J et al (1992) White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer’s disease. Evidence for heterogeneity. Brain 115:735–748CrossRefPubMed Scheltens P, Barkhof F, Valk J et al (1992) White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer’s disease. Evidence for heterogeneity. Brain 115:735–748CrossRefPubMed
18.
Zurück zum Zitat Stenson PD, Mort M, Ball EV et al (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1–9PubMedCentralCrossRefPubMed Stenson PD, Mort M, Ball EV et al (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1–9PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Ueda A, Hirano T, Takahashi K et al (2009) Detection of granular osmiophilic material of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy by light microscopy in frozen sections. Neuropathol Appl Neurobiol 35:618–622CrossRefPubMed Ueda A, Hirano T, Takahashi K et al (2009) Detection of granular osmiophilic material of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy by light microscopy in frozen sections. Neuropathol Appl Neurobiol 35:618–622CrossRefPubMed
20.
21.
Zurück zum Zitat Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295–305PubMedCentralCrossRefPubMed Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295–305PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Peters N, Opherk C, Bergmann T et al (2005) Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol 62:1091–1094CrossRefPubMed Peters N, Opherk C, Bergmann T et al (2005) Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol 62:1091–1094CrossRefPubMed
23.
24.
Zurück zum Zitat Mykkänen K, Savontaus ML, Juvonen V et al (2004) Detection of the founder effect in Finnish CADASIL families. Eur J Hum Genet 12:813–819CrossRefPubMed Mykkänen K, Savontaus ML, Juvonen V et al (2004) Detection of the founder effect in Finnish CADASIL families. Eur J Hum Genet 12:813–819CrossRefPubMed
25.
Zurück zum Zitat Kim Y, Choi EJ, Choi CG et al (2006) Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology 66:1511–1516CrossRefPubMed Kim Y, Choi EJ, Choi CG et al (2006) Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology 66:1511–1516CrossRefPubMed
26.
Zurück zum Zitat Scheid R, Heinritz W, Leyhe T et al (2008) Cysteine-sparing NOTCH3 mutations: CADASIL or CADASIL variants? Neurology 71:774–776CrossRefPubMed Scheid R, Heinritz W, Leyhe T et al (2008) Cysteine-sparing NOTCH3 mutations: CADASIL or CADASIL variants? Neurology 71:774–776CrossRefPubMed
27.
Zurück zum Zitat Bersano A, Ranieri M, Ciammola A et al (2012) Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant. Funct Neurol 27:247–252PubMedCentralPubMed Bersano A, Ranieri M, Ciammola A et al (2012) Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant. Funct Neurol 27:247–252PubMedCentralPubMed
29.
Zurück zum Zitat Brass SD, Smith EE, Arboleda-Velasquez JF et al (2009) Case records of the Massachusetts General Hospital. Case 12-2009. A 46-year-old man with migraine, aphasia, and hemiparesis and similarly affected family members. N Engl J Med 360:1656–1665CrossRefPubMed Brass SD, Smith EE, Arboleda-Velasquez JF et al (2009) Case records of the Massachusetts General Hospital. Case 12-2009. A 46-year-old man with migraine, aphasia, and hemiparesis and similarly affected family members. N Engl J Med 360:1656–1665CrossRefPubMed
30.
Zurück zum Zitat Joutel A, Favrole P, Labauge P et al (2001) Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358:2049–2051CrossRefPubMed Joutel A, Favrole P, Labauge P et al (2001) Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358:2049–2051CrossRefPubMed
31.
Zurück zum Zitat Lesnik Oberstein SA, van Duinen SG, van den Boom R et al (2003) Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol 106:107–111CrossRefPubMed Lesnik Oberstein SA, van Duinen SG, van den Boom R et al (2003) Evaluation of diagnostic NOTCH3 immunostaining in CADASIL. Acta Neuropathol 106:107–111CrossRefPubMed
32.
Zurück zum Zitat Malandrini A, Gaudiano C, Gambelli S et al (2007) Diagnostic value of ultrastructural skin biopsy studies in CADASIL. Neurology 68:1430–1432CrossRefPubMed Malandrini A, Gaudiano C, Gambelli S et al (2007) Diagnostic value of ultrastructural skin biopsy studies in CADASIL. Neurology 68:1430–1432CrossRefPubMed
33.
Zurück zum Zitat Markus HS, Martin RJ, Simpson MA et al (2002) Diagnostic strategies in CADASIL. Neurology 59:1134–1138CrossRefPubMed Markus HS, Martin RJ, Simpson MA et al (2002) Diagnostic strategies in CADASIL. Neurology 59:1134–1138CrossRefPubMed
Metadaten
Titel
Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014
verfasst von
Akihiko Ueda
Mitsuharu Ueda
Akihito Nagatoshi
Teruyuki Hirano
Takaaki Ito
Nobutaka Arai
Eiichiro Uyama
Kota Mori
Masaaki Nakamura
Satoru Shinriki
Katsuyoshi Ikeda
Yukio Ando
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7782-8

Weitere Artikel der Ausgabe 8/2015

Journal of Neurology 8/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.